ArticleBMC biotechnology2021

Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin.

Sara Gómez-Melero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.